Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs160652 | chr7:65538431 | A/G | 6.46E-6 | 292 | 21.27 | 21.97 | 4.62 | KM Plot |
CESC | rs160653 | chr7:65536780 | A/G | 6.82E-7 | 294 | 21.27 | 21.3 | 7.57 | KM Plot |
CESC | rs160657 | chr7:65546356 | C/T | 7.25E-6 | 292 | 21.2 | 22.45 | 4.62 | KM Plot |
CESC | rs1642851 | chr14:76985410 | C/T | 2.71E-5 | 299 | 22.28 | 20.43 | 9.17 | KM Plot |
CESC | rs16832082 | chr3:161043571 | A/G | 1.0E-5 | 296 | 25.82 | 20.38 | 19.05 | KM Plot |
CESC | rs16861032 | chr3:113187675 | C/G | 3.31E-8 | 299 | 2.47 | 21.3 | 21.85 | KM Plot |
CESC | rs16878137 | chr8:109567733 | G/A | 3.64E-5 | 289 | 21.3 | 21.62 | 11.6 | KM Plot |
CESC | rs16878143 | chr8:109568370 | A/C | 3.8E-5 | 288 | 21.3 | 21.27 | 11.6 | KM Plot |
CESC | rs16942887 | chr16:67928042 | G/A | 2.43E-6 | 295 | 20.43 | 28.77 | 17.15 | KM Plot |
CESC | rs16953134 | chr15:69618161 | G/T | 3.29E-8 | 299 | 21.4 | 22.07 | 4.55 | KM Plot |
CESC | rs16970649 | chr19:36222857 | C/T | 5.89E-5 | 290 | 21.2 | 24.63 | 3.17 | KM Plot |
CESC | rs1703925 | chr8:608279 | A/G | 9.61E-5 | 293 | 4.2 | 19.17 | 21.27 | KM Plot |
CESC | rs17089409 | chr13:73065166 | A/C | 2.54E-7 | 299 | 5.23 | 23.3 | 21.2 | KM Plot |
CESC | rs17107449 | chr10:81715696 | C/T | 4.01E-9 | 297 | 25.17 | 16.42 | 2.62 | KM Plot |
CESC | rs17118370 | chr8:13893230 | C/T | 2.46E-9 | 299 | 21.27 | 21.65 | 7.48 | KM Plot |